[HTML][HTML] Antibiotics in the clinical pipeline as of December 2022

MS Butler, IR Henderson, RJ Capon… - The Journal of …, 2023 - nature.com
The need for new antibacterial drugs to treat the increasing global prevalence of drug-
resistant bacterial infections has clearly attracted global attention, with a range of existing …

Metal/metal oxide nanoparticles: A revolution in the biosynthesis and medical applications

RA de Jesus, GC de Assis, RJ de Oliveira… - Nano-Structures & Nano …, 2024 - Elsevier
Nanoparticles with their various physical and chemical properties are commonly applied in
the environmental remediation systems, as well as in the field of biomedicine. We report the …

Current developments in antibiotic discovery: Global microbial diversity as a source for evolutionary optimized anti‐bacterials

JD Hegemann, J Birkelbach, S Walesch, R Müller - EMBO reports, 2023 - embopress.org
Antibiotics have profoundly revolu-tionized medicine and the health care sector since
Alexander Fleming first identified the bacteria-killing properties of penicillin. The following …

Aminoglycoside uptake, stress, and potentiation in Gram-negative bacteria: new therapies with old molecules

M Lang, A Carvalho, Z Baharoglu… - … and Molecular Biology …, 2023 - Am Soc Microbiol
Aminoglycosides (AGs) are long-known molecules successfully used against Gram-negative
pathogens. While their use declined with the discovery of new antibiotics, they are now …

[HTML][HTML] Evaluating the innovative potential of the global antibacterial pipeline

U Theuretzbacher - Clinical Microbiology and Infection, 2023 - Elsevier
Background Resistance burden varies widely among WHO regions, and the potential impact
of new antibiotics differs in addressing the WHO's critical priority pathogens' resistance …

The pearl jubilee of microcin J25: thirty years of research on an exceptional lasso peptide

F Baquero, K Beis, DJ Craik, Y Li, AJ Link… - Natural Product …, 2024 - pubs.rsc.org
Covering: 1992 up to 2023 Since their discovery, lasso peptides went from peculiarities to
be recognized as a major family of ribosomally synthesized and post-translationally modified …

An overview of Cefiderocol's therapeutic potential and underlying resistance mechanisms

S Domingues, T Lima, MJ Saavedra, GJ Da Silva - Life, 2023 - mdpi.com
Antimicrobial resistance continues to increase globally and treatment of difficult-to-treat
(DTT) infections, mostly associated with carbapenem-resistant (CR) Pseudomonas …

6, 7-Coumarin-heterocyclic hybrids: a comprehensive review of their natural sources, synthetic approaches, and bioactivity

NM Zeki, YF Mustafa - Journal of Molecular Structure, 2024 - Elsevier
The hybridization of heterocycles presents a key opportunity to craft innovative multicyclic
compounds with enhanced biological activity. Coumarins, being broadly prevalent natural …

New genetically engineered derivatives of antibacterial darobactins underpin their potential for antibiotic development

CE Seyfert, AV Müller, DJ Walsh… - Journal of Medicinal …, 2023 - ACS Publications
Biosynthetic engineering of bicyclic darobactins, selectively sealing the lateral gate of the
outer membrane protein BamA, leads to active analogues, which are up to 128-fold more …

Treatment of antibiotic-resistant genes via photocatalytic-assisted Microbial Fuel Cells: A review

A Ahtesham, M Shahadat, E Hussain, R Adnan… - Journal of Water …, 2023 - Elsevier
Antibiotic-resistant genes (ARGs) have emerged in water bodies due to the discharge of
huge amounts of antibiotics into wastewater. Well-planned and designed configurational …